Dividend Articles | Dividend Channel

Look Under The Hood: ESML Has 17% Upside
Dividend Channel Staff - Tuesday, April 30, 9:23 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares ESG Aware MSCI USA Small-Cap ETF (ESML), we found that the implied analyst target price for the ETF based upon its underlying holdings is $44.91 per unit. Read More »

First Week of June 21st Options Trading For Syndax Pharmaceuticals (SNDX)
Dividend Channel Staff - Friday, April 19, 11:38 AM

Investors in Syndax Pharmaceuticals Inc (SNDX) saw new options become available this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SNDX options chain for the new June 21st contracts and identified one put and one call contract of particular interest. Read More »

Noteworthy Wednesday Option Activity: SNDX, BYON, CNXC
Dividend Channel Staff - Wednesday, March 27, 3:24 PM

Noteworthy Tuesday Option Activity: EHC, CLF, SNDX
Dividend Channel Staff - Tuesday, March 19, 3:28 PM

FYC's Underlying Holdings Could Mean 17% Gain Potential
Dividend Channel Staff - Wednesday, March 13, 6:56 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Small Cap Growth AlphaDEX Fund ETF (FYC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $74.15 per unit. Read More »

Noteworthy Friday Option Activity: DPZ, IMXI, SNDX
Dividend Channel Staff - Friday, March 8, 3:19 PM

Implied FYC Analyst Target Price: $71
Dividend Channel Staff - Thursday, February 8, 6:53 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Small Cap Growth AlphaDEX Fund ETF (FYC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $71.15 per unit. Read More »

Notable Thursday Option Activity: GNRC, SNDX, LW
Dividend Channel Staff - Thursday, January 25, 3:21 PM

First Week of SNDX March 15th Options Trading
Dividend Channel Staff - Monday, January 22, 10:56 AM

Investors in Syndax Pharmaceuticals Inc (SNDX) saw new options begin trading this week, for the March 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SNDX options chain for the new March 15th contracts and identified one put and one call contract of particular interest. Read More »

Sum Up The Parts: XBI Could Be Worth $133
Dividend Channel Staff - Monday, January 8, 9:11 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&P Biotech ETF (XBI), we found that the implied analyst target price for the ETF based upon its underlying holdings is $133.11 per unit. Read More »

Syndax Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for SNDX
Dividend Channel Staff - Thursday, December 14, 3:38 PM

Peek Under The Hood: SMMV Has 13% Upside
Dividend Channel Staff - Monday, December 4, 7:05 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $39.27 per unit. Read More »

Implied OMFS Analyst Target Price: $45
Dividend Channel Staff - Friday, November 3, 7:20 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Russell 2000—Dynamic Multifactor ETF (OMFS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $45.48 per unit. Read More »

Commit To Buy Syndax Pharmaceuticals At $10, Earn 26.9% Annualized Using Options
Dividend Channel Staff - Thursday, October 19, 2:29 PM

Syndax Pharmaceuticals Enters Oversold Territory (SNDX)
Dividend Channel Staff - Thursday, October 12, 11:38 AM

We Did The Math XBI Can Go To $137
Dividend Channel Staff - Tuesday, October 3, 6:57 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&P Biotech ETF (XBI), we found that the implied analyst target price for the ETF based upon its underlying holdings is $137.00 per unit. Read More »

Notable Wednesday Option Activity: GVA, SNDX, ENVX
Dividend Channel Staff - Wednesday, September 27, 3:19 PM

Noteworthy Friday Option Activity: MDRX, SNDX, PENN
Dividend Channel Staff - Friday, September 15, 3:31 PM

Syndax Pharmaceuticals is Now Oversold (SNDX)
Dividend Channel Staff - Friday, September 15, 11:52 AM

Notable Thursday Option Activity: TRTN, SPWH, SNDX
Dividend Channel Staff - Thursday, September 7, 3:44 PM

Analysts Expect XBI To Hit $138
Dividend Channel Staff - Wednesday, August 30, 7:23 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&P Biotech ETF (XBI), we found that the implied analyst target price for the ETF based upon its underlying holdings is $138.27 per unit. Read More »

Noteworthy Tuesday Option Activity: SPHR, FSLR, SNDX
Dividend Channel Staff - Tuesday, August 22, 6:24 PM

The Implied Analyst 12-Month Target For SMMV
Dividend Channel Staff - Thursday, July 27, 7:23 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $39.65 per unit. Read More »

Commit To Purchase Syndax Pharmaceuticals At $17.50, Earn 51.6% Annualized Using Options
Dividend Channel Staff - Friday, July 21, 2:10 PM

Add Up The Parts: PTH Could Be Worth $148
Dividend Channel Staff - Monday, June 12, 8:04 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco DWA Healthcare Momentum ETF (PTH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $147.63 per unit. Read More »

Friday 10/11 Insider Buying Report: SNDX, TLRD
Dividend Channel Staff - Friday, October 11, 1:42 PM

Older articles »